Young Eun Ha
Overview
Explore the profile of Young Eun Ha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Myung R, Kim B, Kim J, Kim T, Lee M, et al.
J Korean Med Sci
. 2024 Apr;
39(12):e118.
PMID: 38565175
Background: Since the emergence of hypervirulent strains of , the incidence of infections (CDI) has increased significantly. Methods: To assess the incidence of CDI in Korea, we conducted a prospective...
2.
Huh K, Chung D, Ha Y, Ko J, Huh H, Lee N, et al.
Int J Infect Dis
. 2023 May;
134:8-14.
PMID: 37172775
Objectives: It is unclear whether the poor outcome of patients with severe vancomycin-resistant enterococci (VRE) infection is attributable to vancomycin resistance or to Enterococcus faecium (Efm), which predominates among VRE....
3.
Huh K, Chung D, Ha Y, Ko J, Kim S, Kim M, et al.
Clin Infect Dis
. 2020 Jan;
71(9):e487-e496.
PMID: 31994704
Background: Clinically relevant categorization of antimicrobial resistance is critical to mitigating the threat it poses. Difficult-to-treat resistance (DTR) is a recently proposed category defined as nonsusceptibility to all first-line antibiotic...
4.
Song T, Lee S, Ha Y, Choi K, Lee S, Kim Y, et al.
Diabetes Res Clin Pract
. 2019 Jan;
PMID: 30641165
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can...
5.
Seok H, Cha M, Kang C, Cho S, Kim S, Ha Y, et al.
Infect Chemother
. 2019 Jan;
50(4):357-361.
PMID: 30600660
While carbapenems are the drug of choice to treat extended-spectrum-β-lactamase (ESBL)-producing strains, some alternative carbapenem-sparing regimens are suggested for antibiotic stewardship. We experienced a case of ciprofloxacin treatment failure for...
6.
Ko J, Peck K, Jung D, Lee J, Kim H, Ryu S, et al.
Diagn Microbiol Infect Dis
. 2018 Jun;
92(2):127-132.
PMID: 29929855
To evaluate the impacts of fluconazole minimum inhibitory concentration (MIC) according to primary antifungal agents on Candida glabrata bloodstream infection (BSI), a multicenter retrospective cohort study was conducted in Korea,...
7.
Ko J, Seok H, Cho S, Ha Y, Baek J, Kim S, et al.
Antivir Ther
. 2018 Jun;
23(7):617-622.
PMID: 29923831
Background: The effects of convalescent plasma (CP) infusion, one of the treatment options for severe Middle East respiratory syndrome coronavirus (MERS-CoV) infections, have not yet been evaluated. Methods: Serological responses...
8.
Huh K, Chung D, Kim S, Cho S, Ha Y, Kang C, et al.
Eur J Clin Microbiol Infect Dis
. 2018 May;
37(8):1547-1552.
PMID: 29777487
To evaluate the effects of demographic and perceptive factors on the knowledge, perception, and behavior regarding antibiotic use in the general public, we conducted three serial telephone interview surveys in...
9.
Seok H, Kang C, Huh K, Cho S, Ha Y, Chung D, et al.
Microb Drug Resist
. 2018 Mar;
24(9):1412-1416.
PMID: 29565225
Background: Fluoroquinolones are antibiotics commonly used in the treatment of infections caused by Streptococcus pneumoniae. However, rates of fluoroquinolone resistance are increasing with their frequent use. We designed this study...
10.
Ko J, Seok H, Park G, Lee J, Lee J, Cho S, et al.
J Infect Chemother
. 2017 Dec;
24(2):150-152.
PMID: 29223614
To evaluate host susceptibility factors to Middle East respiratory syndrome coronavirus (MERS-CoV) infection, we conducted a retrospective cohort study from the single largest exposure event of the 2015 Korean MERS...